TEVA - TEVA PHARMACEUTICAL INDS LTD
This page shows which of the focused investors we track hold TEVA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2023 it was held by 4 managers with an aggregate reported value of $63.29M, which is 0.01% of the combined portfolio.
As of Q2 2023, 4 tracked institutional managers held TEVA (TEVA PHARMACEUTICAL INDS LTD) with an aggregate reported value of $63.29M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TEVA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2023
- Ticker
- TEVA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Abrams - Abrams Capital Management | 1.73% | - | 7,966,433 | $59.99M |
| 2 | Samantha McLemore - Patient Capital Management | 0.13% | Reduce -51.1% | 306,054 | $2.3M |
| 3 | Bill Miller - Miller Value Partners | 0.41% | Reduce -97.9% | 82,137 | $618.49K |
| 4 | Lee Ainslie - Maverick Capital | 0.01% | Reduce -4.3% | 50,588 | $380.93K |
Loading holder history for TEVA…